Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perforomist vs Foradil in COPD
NCT00633776Phase 4Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by University of California, Los Angeles. Planned start Mar 2008; status: withdrawn.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00633776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633776.